Drug
Ropinirole clinical trials
Also written Requip.
- studies test it
- 35
- open now
- 0
- in phase 3
- 10
- first study started
- 2001
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
35 studies that test it; most in 2005 (7)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 8
- Phase 3
- 10
- Phase 4
- 8
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 25 · Other 10
GlaxoSmithKline (14) · Roxane Laboratories (2) · Dr. Reddy's Laboratories Limited (2) · Teva Pharmaceuticals USA (2) · Columbia University (1) · Vanderbilt University Medical Center (1) · The University of Texas Health Science Center, Houston (1) · Cambridge Health Alliance (1)
Often tested with
Tested in the same studies.
Levodopa (3) · Pramipexole (2) · Carbidopa (1) · Rasagiline (1) · U 95666E (1) · Gabapentin (1)
Studies
Open first, then newest update. How each study uses ropinirole is read from its arms, and is right about nine times in ten.
Testing it · 35
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist RopiniroleCompletedPhase 1/2Columbia UniversityNCT03038308Written as Ropinirole
- Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTerminatedPhase 1/2Titan PharmaceuticalsNCT03250117Written as Ropinirole oral product
- Ropinirole for the Treatment of Muscle Cramps in Patients With CirrhosisCompletedPhase 4Vanderbilt University Medical CenterNCT03176966Written as Ropinirole
- Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HDTerminatedPhase 2University of AlbertaNCT03708237Written as Ropinirole
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)CompletedPhase 3GlaxoSmithKlineNCT00256854Written as Ropinirole IR 1 mg
- A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's DiseaseCompletedPhase 4GlaxoSmithKlineNCT01494532Written as ropinirole/L-dopa
- Ropinirole PR Pharmacokinetics Study Among Chinese Healthy SubjectsCompletedPhase 1GlaxoSmithKlineNCT01435915Written as Ropinirole
- Cognitive Remediation for Cocaine DependenceCompletedPhase 2The University of Texas Health Science Center, HoustonNCT01393457Written as Ropinirole 2 mg/d
- A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00674310Written as Ropinirole Hydrochloride
- A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted ConditionsCompletedNot applicableRoxane LaboratoriesNCT00673088Written as Ropinirole Hydrochloride
- Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of FoodCompletedPhase 1GlaxoSmithKlineNCT00419692Written as Ropinirole
- Ropinirole in the Treatment of Bipolar DepressionCompletedPhase 4Cambridge Health AllianceNCT00314821Written as ropinirole
- Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopaCompletedPhase 3GlaxoSmithKlineNCT00381472Written as Ropinirole
- Long-term Study Of Ropinirole In Restless Legs SyndromeCompletedPhase 4GlaxoSmithKlineNCT00329602Written as Ropinirole
- Trial of Ropinirole in Motor Recovery After StrokeCompletedPhase 2University of California, IrvineNCT00221390Written as Ropinirole (+ physical therapy)
- Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of RopiniroleCompletedPhase 2GlaxoSmithKlineNCT00460148Written as Ropinirole
- Long-Term Safety Of Ropinirole XR In Patients With Restless Legs SyndromeCompletedPhase 3GlaxoSmithKlineNCT00355641Written as Ropinirole Extended Release (XR)
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of RopiniroleCompletedPhase 3GlaxoSmithKlineNCT00314860Written as ropinirole Extended Release (XR)
- A Clinical Research Study Testing Ropinirole Treatment for Restless Legs SyndromeCompletedPhase 3GlaxoSmithKlineNCT00363857Written as Ropinirole
- Ropinirole XR (Extended Release) In Patients With Restless Legs SyndromeCompletedPhase 3GlaxoSmithKlineNCT00197080Written as Ropinirole Extended Release (XR)
See all 35 studies that test ropinirole →
As the comparator · 3 — what is tested is compared with ropinirole
- Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis PatientsCompletedNot applicableLahore General HospitalNCT06468371Written as Dopamine Agonist (Ropinirole)
- Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's DiseaseCompletedPhase 3GlaxoSmithKlineNCT00823836Written as ropinirole IR
- A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease PatientsCompletedPhase 3Otsuka Pharmaceutical Co., Ltd.NCT01628926Written as Ropinirole
Codes
What other systems call ropinirole · ClinicalTrials.gg INT003236
- MeSH (NLM) C046649ropiniroleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 030PYR8953ROPINIROLEConfirmed FDA, NLM, Wikidata
- RxNorm 72302Confirmed FDA, Wikidata
- Wikidata Q420590ropinirolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61931RopiniroleOne source FDA
- DrugBank DB00268One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C046649 | ropinirole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 030PYR8953 | ROPINIROLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 72302 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420590 | ropinirol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61931 | Ropinirole | One source FDA |
| DrugBank | DB00268 | — | One source Wikidata |
Also registered as ropinirole hydrochloride (UNII D7ZD41RZI9 · RxNorm 236553).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.